NOD1 and viral infectious disease: Regarding the antiviral capacity of the NOD1 pathway in the context of viral infections, previous results demonstrated that NOD1 agonist DAP inhibits viral replication of HBV in pretreated C57BL/w mice by decreasing HB antigen and DNA levels due to enhanced T cell activation and immune response [31].